Senior insider sale
SVP, GC & Corporate Secretary at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$3.00M
87.67K shares
What this filing means
REED ELIZABETH E plans to sell 87.67K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $3.00M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/14/2026ACC: 0001950047-26-003425
Officer· SVP, GC & Corporate Secretary
Since Nov 2018
87.67K
Shares to sell
$3.00M
Approx. market value
37.50K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
4/14/2026
37.50KTotal acquired37.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/14/2026 | Stock Option Exercise Cash | 37.50K | — |
| Total | 37.50K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
10K
Market value
$300.0K
4/1/2026
—Completed
Units to sell
10K
Market value
$280.9K
3/16/2026
—Completed
Units to sell
10K
Market value
$278.3K
2/17/2026
—Completed
Units to sell
2.99K
Market value
$96.4K
2/4/2026
—Completed
Units to sell
7.17K
Market value
$230.5K
2/3/2026
—Completed
Units to sell
10K
Market value
$273.4K
1/20/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
37.50K
Market value
$1.54M
4/14/2026
Total
Units
87.67K
Value
$3.00M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/1/2026 | 10K | $300.0K | — | Completed |
3/16/2026 | 10K | $280.9K | — | Completed |
2/17/2026 | 10K | $278.3K | — | Completed |
2/4/2026 | 2.99K | $96.4K | — | Completed |
2/3/2026 | 7.17K | $230.5K | — | Completed |
1/20/2026 | 10K | $273.4K | — | Completed |
| Planned — Approximate Date | ||||
4/14/2026 | 37.50K | $1.54M | NASDAQ | Planned |
| Total | 87.67K | $3.00M | ||